Dr. Nathan Punwani, MD

Dr. Punwani practices at Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona.

Dr. Punwani's NPI, 1053751800, was assigned on June 25, 2013. Dr. Punwani graduated from Drexel University College Of Medicine in 2013. Dr. Punwani holds Arizona license 62474.

Dr. Punwani's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale, at 13400 East Shea Boulevard, Scottsdale, AZ 85259. The practice phone is (480) 342-4201.

Dr. Punwani's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona. Dr. Punwani is also affiliated with Mayo Clinic Hospital - Phoenix. The medical group on file is Mayo Clinic Arizona. Dr. Punwani's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Punwani practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Punwani's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Punwani is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Punwani's licenses on file in 4 states: Arizona, California, District of Columbia and Virginia.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and immune deficiency disease among the conditions Dr. Punwani treats.

CMS data shows 83,317 Medicare services from Dr. Punwani across 56 procedure codes in 2024, for 845 Medicare patients. Medicare paid $1,741,815 for them.

CMS counts 845 Medicare patients who saw Dr. Punwani in 2024. The largest group is 65 to 74, with 431 patients. 71% of them have high cholesterol, and 69% have high blood pressure. 3% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Punwani's median patient age at 70, with 49% women.

In 2024, Dr. Punwani wrote 811 Medicare Part D claims for 123 patients. 70% of them were for generic drugs. CMS names the drug for 515 of them, across 19 drugs with 11 or more claims each, at $3,093,915 in total drug cost. In 2023, CMS named 329 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Punwani for performance year 2024, reported as part of a group. Dr. Punwani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Punwani as offering telehealth.

Dmand AI links 13 papers to Dr. Punwani, published from 2012 to 2019. 2013 was the busiest year, with 3. The most frequent topics are Patient Safety, Accreditation and Ambulatory Surgical Procedures. Dr. Punwani has published most often in AORN J. Dr. Punwani's most frequent co-authors are Richard Dennis Urman, MD, Fred E. Shapiro, DO and Maryanne C. Bombaugh, MD.

Dmand AI links Dr. Punwani to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Burkitt Lymphoma, Leukemia, Myeloid, Acute and Epstein-Barr Virus Infections.

CMS Open Payments shows 32 general payments to Dr. Punwani from 13 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 93% of the total. Amgen Inc. paid the most, $479.

Dr. Punwani graduated from Drexel University College Of Medicine in 2013. Dr. Punwani is a member of AMA, ASCO and ASH.

Dr. Punwani is in network with 9 carriers, including Excellus BlueCross BlueShield, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.